封面
市場調查報告書
商品編碼
1197922

外周靜脈導管市場——增長、趨勢、COVID-19 的影響和預測 (2023-2028)

Peripheral Intravenous Catheters Market - Growth, Trends, and Forecasts (2023 - 2028)

出版日期: | 出版商: Mordor Intelligence | 英文 122 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內,全球外周靜脈導管市場預計將以約 6.5% 的複合年增長率增長。

全球 COVID-19 病例數量的激增和封鎖情況對市場產生了重大影響,因為治療、診斷和手術等服務最初被擱置以防止 COVID-19 的傳播。曾是。 然而,隨著全球 COVID-19 病例數的增加,它也導致住院人數增加。 隨著政府和醫療機構提高對 COVID-19 患者的護理效率,醫院和急診室對導管的需求量很大。 2021 年 7 月發表在國家醫學圖書館的一項研究發現,在門診和門診診所,89.2% 的血管外科醫生報告了更短的諮詢時間 (71%) 和使用遠程醫療服務 (81.1%) 等變化。 因此,血管手術和非 COVID-19 患者住院的減少阻礙了 COVID-19 期間的市場增長。 此外,隨著所有限制的解除和門診治療數量的增加,預計市場擴張將在預測期內恢復。

心血管、神經和泌尿系統疾病患病率上升,導管中先進材料的使用增加,以及對微創手術的需求增加,推動了市場的發展。 在過去的 30 年裡,心血管、泌尿系統和神經系統疾病一直是全球死亡率和發病率的主要原因。 在預測期內,越來越多地使用外周靜脈導管治療這些涉及住院的慢性疾病預計將推動市場。 例如,根據 2021 年 7 月發表在《循環》雜誌上的一項研究,外周動脈疾病 (PAD) 影響著全世界超過 2.3 億人,並導致多種有害疾病,包括冠心病和中風。與臨床風險增加相關結果。 因此,預計 PAD 的全球高發病率及其相關風險因素將在預測期內推動對外周靜脈導管的需求。

此外,根據聯合國2021年2月公佈的數據,到2020年,地球上將有超過10億人,即近六分之一的人患有阿爾茨海默病、帕金森病、中風和多發性硬化症。據說患有癲癇、癲癇性偏頭痛、腦外傷、神經感染等神經系統疾病。 據同一消息人士稱,到2020年,全球將有6200萬人患有腦血管病,5000萬人患有癲癇症,3.26億人患有偏頭痛,2400萬人患有阿爾茨海默病和其他癡呆症。 因此,預計心血管和神經系統疾病患病率上升將推動市場增長。

因此,上述所有因素都有望在預測期內推動市場增長。 然而,與外周靜脈導管相關的風險和並發症可能會阻礙全球外周靜脈導管市場的增長。

外周靜脈導管市場趨勢

集成/封閉式導管主導市場,預計在預測期內將繼續如此

在整個預測期內,集成/封閉式導管預計將主導外周靜脈導管市場。 越來越多地採用有助於在計算機斷層掃描 (CT) 期間注入造影劑的封閉式導管是該領域的增長動力。 這些導管由聚氨酯材料製成,可承受超過 300 磅/平方英寸 (psi) 的壓力。

根據 2022 年 8 月發表在《英國護理雜誌》上的一項研究,緊密/整體導管可降低醫護人員接觸患者血液的風險,並允許安全地採集血液樣本。 它可以防止回流到插管尖端,降低阻塞風險和多次插入的需要。 此外,設備在插入後必須保持穩定,以盡量減少血管內的微動,微動會損壞內膜並導致機械性靜脈炎。 因此,由於上述優勢,緊配合/整體導管預計在預測期內需求增加,從而推動該細分市場的增長。

此外,市場參與者的各種戰略活動(例如產品發布、併購和合作夥伴關係)預計將在預測期內推動細分市場的增長。 例如,2022年7月,B. Braun Medical Inc.(B. Braun)推出了Introcan Safety 2 IV Catheter,能夠進行單次血液控制。 Introcan Safety 2 IV 導管是 B. Braun 的最新創新,旨在降低針刺傷和血液暴露的風險,使臨床醫生的 IV 通路更安全。

因此,上述所有因素預計將在預測期內推動該細分市場的增長。

北美主導市場,預計在預測期內將繼續保持這一勢頭

北美佔據了大部分市場份額。 該地區受到慢性病增加和人口老齡化的困擾。 北美擁有先進的醫療保健設施和廣泛的保險報銷範圍,有助於在該地區佔據較大的市場份額。 例如,根據 Alzheimers.org 的數據,到 2021 年,美國將有 620 萬 65 歲及以上的美國人患有與阿爾茨海默病相關的癡呆症。 帕金森基金會還估計,到 2020 年將有近 100 萬美國人患有帕金森病 (PD)。 據同一消息來源稱,每年有近 60,000 名美國人被診斷出患有帕金森症。 因此,預計神經系統疾病患病率上升將增加對外周靜脈導管的需求,從而推動市場增長。

此外,人口老齡化更容易患心血管和神經系統疾病,因此預計老年人口的增加將推動市場增長。 根據加拿大統計局的一份報告,到 2021 年 7 月,大約 18.5% 的加拿大人口將超過 65 歲,高於 2020 年 7 月的 17.5%。 此外,根據 2020 年全球人口老齡化報告,美國 65 歲及以上人口超過 4600 萬,預計到 2050 年這一數字將增長到近 9000 萬。 此外,預計 2020 年至 2030 年間老年人口將增加近 1800 萬。 因此,預計易患心髒病的老年人口增加將增加對外周靜脈導管的需求,從而推動該地區的市場增長。

此外,主要市場參與者推出的產品將支持市場擴張。 例如,2022年9月,B. Braun Medical Inc.(B. Braun)宣布收購Starboard Medical, Inc.專有的Clik-FIX導管固定裝置產品組合。 B.Braun 的收購擴展了公司產品和項目創新的歷史,以改善外周靜脈 (IV) 治療的患者體驗和結果。 因此,上述所有因素預計將推動該地區的市場增長。

外周靜脈導管市場競爭者分析

外周靜脈導管市場競爭激烈,既有本地公司也有跨國公司。 由於技術進步,中小型企業將重點放在市場滲透和獲得市場份額上。 目前市場上的公司包括 B. Braun Melsungen AG、BD、ICU Medical、Smiths Medical、Teleflex Incorporated、Terumo IS 和 Vygon SA。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章研究方法論

第 3 章執行摘要

第4章市場動態

  • 市場概覽
  • 市場驅動因素
    • 心血管、神經和泌尿系統疾病的患病率增加
    • 增加導管中使用的尖端材料
    • 增加微創手術的頻率
  • 市場製約因素
    • 與導管相關的風險和並發症
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分(基於價值的市場規模:百萬美元)

  • 按產品分類
    • 集成/閉合導管
    • 外周插入導管
  • 最終用戶
    • 醫院
    • 門診手術中心
    • 其他最終用戶
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章競爭格局

  • 公司簡介
    • B. Braun Melsungen AG
    • BD
    • ICU Medical(Smiths Medical)
    • Lineus Medical
    • Teleflex Incorporated
    • Terumo IS
    • Vygon SA
    • NIPRO Medical Corporation
    • VOGT Medical
    • RenovoRx Inc.
    • Retractable Technologies Inc.
    • MedSource Labs

第7章 市場機會與今後動向

簡介目錄
Product Code: 68187

The global peripheral intravenous catheters market is anticipated to grow with a CAGR of nearly 6.5% during the forecast period.

The escalating number of COVID-19 cases worldwide, as well as the lockdown scenario, had a substantial influence on the market, initially due to on-hold services such as treatment, diagnostic, and surgical services, to prevent the spread of COVID-19. However, the growing number of COVID-19 cases worldwide contributed to an increase in the number of in-patient admissions. Catheters were in high demand in hospitals and emergency clinics as governments and healthcare institutions sought to improve the efficiency of medical treatment for COVID-19 patients. According to the study published in the National Library of Medicine in July 2021, in ambulatory care and outpatient clinics, 89.2% of vascular surgeons reported changes to their practice, including fewer hours (71%) and the use of telehealth services (81.1%). Thus, the decline in vascular procedures and non-COVID-19 patient admission hampered the growth of the market during COVID-19. Additionally, the market is anticipated to resume its expansion throughout the projection period as all restrictions are eliminated, and the number of outpatient treatments rises.

The market is driven by the rising prevalence of cardiovascular, neurology, and urology disorders, rising usage of advanced materials in the catheter, and growing demand for minimally invasive surgeries. Cardiovascular, urology, and neurology diseases have become the most dominant cause of mortality and morbidity in the world during the last three decades. Increasing utilization of peripheral intravenous catheters in treating these chronic diseases, leading to hospitalization, is anticipated to drive the market over the forecast period. For instance, per the study article published in Circulation in July 2021, peripheral artery disease (PAD) affects over 230 million persons globally and is linked to an elevated risk of various adverse clinical outcomes, including coronary heart disease, stroke, and others. As a result, the high global incidence of PAD and its associated risk factors are projected to drive demand for peripheral IV catheters over the forecast period.

Additionally, according to data published by the United Nations, in February 2021, in 2020, over 1 billion individuals, or nearly one in every six persons on the planet, would suffer from neurological disorders such as Alzheimer's and Parkinson's disease, strokes, multiple sclerosis, epilepsy migraine, brain traumas, and neuro infections. According to the same source, in 2020, 62 million individuals suffered from cerebrovascular disease, 50 million from epilepsy, 326 million from migraine, and 24 million from Alzheimer's disease and other dementias across the globe. Thus, the growing prevalence of cardiovascular and neurological diseases is expected to boost market growth.

Thus, all aforementioned factors are expected to boost market growth over the forecast period. However, risks and complications associated with peripheral intravenous catheters may hinder the growth of the global peripheral intravenous catheter market.

Peripheral Intravenous Catheters Market Trends

Integrated/Closed Catheters Dominates the Market and Expected to Continue the Same during the Forecast Period

Integrated/closed catheters are expected to dominate the peripheral intravenous catheter market through the forecast period. The increasing adoption of closed catheters that help inject contrast media during computed tomography (CT) is acting as a driving factor for this segment's growth. These catheters are made of polyurethane material and can withstand pressures exceeding 300 pounds per square inch (psi).

According to the study published in the British Journal of Nursing in August 2022, a close/integrated catheter decreases the risk of the healthcare professional coming into contact with the patient's blood and allows for the safe collection of blood samples. It can help prevent backflow into the cannula tip, lowering the danger of blockage and the requirement for several insertions. It is also vital that the device remains stable after insertion to minimize micro-movements within the vessel (which can damage the tunica intima, which can result in mechanical phlebitis. Thus, due to the above benefits, the close/integrated catheter is expected to increase its demand over the forecast period, thereby boosting segment growth.

Furthermore, various strategic activities by market players, such as product launches, mergers, acquisitions, and partnerships, are likely to boost segment growth over the forecast period. For instance, in July 2022, B. Braun Medical Inc. (B. Braun) introduced the Introcan Safety 2 IV Catheter with one-time blood control. The Introcan Safety 2 IV Catheter is B. Braun's latest innovation for making IV access safer for clinicians by lowering the risk of needlestick injuries and blood exposure.

Thus, all the above-mentioned factors are expected to boost segment growth over the forecast period.

North America Dominates the Market and Expected to Continue the Same during the Forecast Period

North America held the majority of the market share. The region suffers from rising chronic diseases and a growing senior population. North America has sophisticated healthcare facilities, and the reimbursement coverage contributes to the large market share of the region. For instance, according to data from Alzheimers.org, 6.2 million Americans aged 65 and older were thought to have Alzheimer's-related dementia in the United States in 2021. Also, the Parkinson's Foundation estimated that nearly 1 million Americans were living with Parkinson's disease (PD) in 2020. As per the same source, nearly 60,000 Americans are diagnosed with Parkinson's disease every year. Thus, the growing prevalence of neurological diseases is expected to boost the demand for peripheral IV catheters, thereby boosting the market growth.

Furthermore, the geriatric population is more prone to cardiovascular and neurological diseases, and thus growing this population is likely to support the growth of the market. As per the Government of Canada Statistics report, as of July 2021, around 18.5% of the Canadian population was aged above 65 years, increasing from 17.5% in July 2020. Additionally, according to the World Population Ageing in 2020, in the United States, there are more than 46 million older adults aged 65 and up; by 2050, that number is expected to rise to nearly 90 million. The number of older adults is expected to rise by nearly 18 million between 2020 and 2030. Thus, the rising geriatric population more prone to cardiac diseases is expected to rise in demand for peripheral IV catheters, thereby driving the market growth in the region.

Furthermore, product launches by the key market players support market expansion. For instance, in September 2022, B. Braun Medical Inc. (B. Braun) reported the acquisition of Starboard Medical, Inc.'s unique Clik-FIX catheter securement device portfolio. The acquisition by B. Braun expands on the company's history of product and program innovation to improve the patient experience and outcomes with peripheral intravenous (IV) therapy. Thus, all the above-mentioned factors are expected to drive market growth in the region.

Peripheral Intravenous Catheters Market Competitor Analysis

The market for peripheral intravenous catheters is highly competitive and consists of global as well as local players. Due to technological advancements, small and mid-sized companies are focusing on market penetration to grab market share. Some of the companies which are currently present in the market are B. Braun Melsungen AG, BD, ICU Medical, Smiths Medical, Teleflex Incorporated, Terumo IS, Vygon SA.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Cardiovascular, Neurology, and Urology Disorders
    • 4.2.2 Growing Usage of the Advanced Materials in the Catheters
    • 4.2.3 Growing Frequency of Minimally Invasive Procedures
  • 4.3 Market Restraints
    • 4.3.1 Risks and Complications Associated with the Catheters
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Integrated/Closed Catheters
    • 5.1.2 Peripheral Insertion Catheters
  • 5.2 By End User
    • 5.2.1 Hospitals
    • 5.2.2 Ambulatory Surgical Centers
    • 5.2.3 Other End Users
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 B. Braun Melsungen AG
    • 6.1.2 BD
    • 6.1.3 ICU Medical (Smiths Medical)
    • 6.1.4 Lineus Medical
    • 6.1.5 Teleflex Incorporated
    • 6.1.6 Terumo IS
    • 6.1.7 Vygon SA
    • 6.1.8 NIPRO Medical Corporation
    • 6.1.9 VOGT Medical
    • 6.1.10 RenovoRx Inc.
    • 6.1.11 Retractable Technologies Inc.
    • 6.1.12 MedSource Labs

7 MARKET OPPORTUNITIES AND FUTURE TRENDS